Cardio Diagnostics Holdings, Inc.
CDIO· Nasdaq
Who holds Cardio Diagnostics Holdings, Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Boothbay Fund Management, LLC | 60.5K | ±0% | $132.6K | 0.1% | Aug 14, 2026 |
| Renaissance Technologies LLC | 49.2K | +220.6% | $107.7K | 0.1% | Aug 13, 2026 |
| BlackRock, Inc. | 34.7K | ±0% | $76K | 0% | Aug 7, 2026 |
| Geode Capital Management, LLC | 26.2K | −18.5% | $57.4K | 0% | Aug 12, 2026 |
| Vanguard Capital Management LLC | 20.2K | ±0% | $44.1K | 0% | Aug 13, 2026 |
| Citadel Advisors LLC | 19.1K | New | $41.8K | 0% | Sep 2, 2026 |
| XTX Topco Ltd | 16.1K | New | $35.2K | 0.1% | Aug 14, 2026 |
| Jane Street Group, LLC | 11.9K | −85.3% | $26.1K | 0% | Aug 14, 2026 |
| State Street Corp | 10.1K | New | $22.1K | 0% | Sep 22, 2026 |
| Vanguard Fiduciary Trust Co | 2.8K | −28.8% | $6.2K | 0% | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 1.8K | −17.5% | $4K | 0.1% | Aug 11, 2026 |
| Saba Capital Management, L.P. | 199.8K | ±0% | $3K | 0.1% | Aug 14, 2026 |
| UBS Group AG | 6.2K | −59.8% | $1.5K | 0% | Aug 13, 2026 |
| Clear Street Group Inc. | 82.3K | ±0% | $1.5K | 0% | Aug 12, 2026 |
| D. E. Shaw & Co., Inc. | 74.8K | ±0% | $1.4K | 0% | Aug 14, 2026 |
| Context Capital Management, LLC | 81.5K | ±0% | $1.2K | 0% | Jul 23, 2026 |
| Wolverine Asset Management LLC | 104 | ±0% | $228 | 0% | Aug 10, 2026 |
| Morgan Stanley | 100 | ±0% | $219 | 0% | Aug 13, 2026 |
| Osaic Holdings, Inc. | 16 | ±0% | $35 | 0% | Aug 14, 2026 |
| SHP Wealth Management | 16 | ±0% | $35 | 0% | Aug 11, 2026 |
| SBI Securities Co., Ltd. | 10 | ±0% | $22 | 0% | Jul 23, 2026 |
| Wells Fargo & Company | 2 | New | $4 | 0% | Aug 14, 2026 |
| Virtu Financial LLC | 21.3K | −30.9% | $0 | 0% | Aug 13, 2026 |